Page last updated: 2024-11-02

phenobarbital and Carcinoma, Bronchogenic

phenobarbital has been researched along with Carcinoma, Bronchogenic in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Carcinoma, Bronchogenic: Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jao, JY1
Jusko, WJ1
Cohen, JL1

Other Studies

1 other study available for phenobarbital and Carcinoma, Bronchogenic

ArticleYear
Phenobarbital effects on cyclophosphamide pharmacokinetics in man.
    Cancer research, 1972, Volume: 32, Issue:12

    Topics: Biotransformation; Carbon Isotopes; Carcinoma, Bronchogenic; Cyclophosphamide; Humans; Lymphoma, Non

1972
chemdatabank.com